An enduring goal of personalized medicine in cancer is the ability to identify patients who
are likely to respond to specific therapies. Our growing understanding of the biology and …

Cell-free DNA (cfDNA) is present in numerous body fluids and generally blood cells. It is
undoubtedly the utmost promising tool among all components of liquid biopsy. Liquid biopsy …

The treatment of cancer has remarkably improved because of increased knowledge of the
abnormalities at the molecular level, which results in human cancer growth. This has …

Abstract Neglected Tropical Diseases (NTDs) continue to ravage the poorest regions of the
world, with over 600 million people being affected in Sub-Saharan Africa. The global burden …

Oral squamous cell carcinoma (OSCC) is a prevalent malignancy of the oral cavity. It arises
from complex interactions between personal lifestyle, genetics, and environmental factors …

The liquid biopsy is a new emerging and repeatable low risky approach able to detect drive
mutations that characterize the tumor, to monitor cancer evolution over time, and to …

Early detection of breast cancer is critical for increasing survival rates. However, currently
available screening strategies provide ambiguous results, leaving invasive tissue biopsy …